异动解读｜康方生物盘中下跌3.04%，回购计划短暂提振后ASCO利好兑现抛压再度主导

行情直击06-15

6月15日，康方生物盘中下跌3.04%，报89.2港元，成交额13.48亿港元。此前公司董事会批准最多2亿港元回购计划曾短暂提振股价，但ASCO利好兑现后的持续抛压再度主导走势。

消息面上，公司核心产品依沃西HARMONi-6研究OS阳性结果于6月1日ASCO全体会议公布后，事件驱动型资金持续获利了结，叠加美方可能限制对中国生物技术投资的传闻扰动及市场对创新药盈利能力的担忧，板块整体承压。尽管多家券商维持买入评级，资金面抛压仍主导短线走势。

（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1150632681?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-15 14:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150632681","market":"us","top_or_hot":-1,"title":"异动解读｜康方生物盘中下跌3.04%，回购计划短暂提振后ASCO利好兑现抛压再度主导","media":"行情直击","content":"<p><p>6月15日，康方生物盘中下跌3.04%，报89.2港元，成交额13.48亿港元。此前公司董事会批准最多2亿港元回购计划曾短暂提振股价，但ASCO利好兑现后的持续抛压再度主导走势。</p><p>消息面上，公司核心产品依沃西HARMONi-6研究OS阳性结果于6月1日ASCO全体会议公布后，事件驱动型资金持续获利了结，叠加美方可能限制对中国生物技术投资的传闻扰动及市场对创新药盈利能力的担忧，板块整体承压。尽管多家券商维持买入评级，资金面抛压仍主导短线走势。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜康方生物盘中下跌3.04%，回购计划短暂提振后ASCO利好兑现抛压再度主导</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜康方生物盘中下跌3.04%，回购计划短暂提振后ASCO利好兑现抛压再度主导\n</h2>\n\n<h4 class=\"meta\">\n\n2026-06-15 14:22 北京时间&nbsp;&nbsp;&nbsp;<strong>行情直击</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月15日，康方生物盘中下跌3.04%，报89.2港元，成交额13.48亿港元。此前公司董事会批准最多2亿港元回购计划曾短暂提振股价，但ASCO利好兑现后的持续抛压再度主导走势。消息面上，公司核心产品依沃西HARMONi-6研究OS阳性结果于6月1日ASCO全体会议公布后，事件驱动型资金持续获利了结，叠加美方可能限制对中国生物技术投资的传闻扰动及市场对创新药盈利能力的担忧，板块整体承压。尽管多家...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09926","symbol_name":"康方生物","start_time":0,"source_url":"","article_id":"1150632681","we_media_id":"1059448697","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150632681","pubTimestamp":1781504520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"行情直击","introduction":"个股异动一手消息解读","home_visible":1,"id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"6月15日，康方生物盘中下跌3.04%，报89.2港元，成交额13.48亿港元。此前公司董事会批准最多2亿港元回购计划曾短暂提振股价，但ASCO利好兑现后的持续抛压再度主导走势。消息面上，公司核心产品依沃西HARMONi-6研究OS阳性结果于6月1日ASCO全体会议公布后，事件驱动型资金持续获利了结，叠加美方可能限制对中国生物技术投资的传闻扰动及市场对创新药盈利能力的担忧，板块整体承压。尽管多家券商维持买入评级，资金面抛压仍主导短线走势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"09926":"康方生物"},"translate_title":"Interpretation of the change | Kangfang Biotech fell 3.04% in the intraday session, and ASCO realized the benefits after the repurchase plan was briefly boosted, and selling pressure again dominated","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09926":1},"content_text":"6月15日，康方生物盘中下跌3.04%，报89.2港元，成交额13.48亿港元。此前公司董事会批准最多2亿港元回购计划曾短暂提振股价，但ASCO利好兑现后的持续抛压再度主导走势。消息面上，公司核心产品依沃西HARMONi-6研究OS阳性结果于6月1日ASCO全体会议公布后，事件驱动型资金持续获利了结，叠加美方可能限制对中国生物技术投资的传闻扰动及市场对创新药盈利能力的担忧，板块整体承压。尽管多家券商维持买入评级，资金面抛压仍主导短线走势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"buyback","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150632681","isCrawlerRequest":true}